Gelmedix

About:

Gelmedix is a developer of a biomaterial platform to improve drug delivery for complicated ophthalmic treatment.

Website: http://www.gelmedix.com

Top Investors: Safar Partners, EQx Fund, HTL Innovations

Description:

Gelmedix is a developer of a biomaterial platform to improve drug delivery for complicated ophthalmic treatment. The company's platform offers a single non-invasive gel patch that can be used as a drug-eluting sealant with tissue adhesion, tunable drug elution, and biocompatibility properties, thereby enabling healthcare providers to reduce the usage of drops which cause inconvenience to patients.

Total Funding Amount:

$1.89M

Headquarters Location:

Newton, Massachusetts, United States

Founded Date:

2020-01-01

Contact Email:

info(AT)gelmedix.com

Founders:

Jeff Behrens

Number of Employees:

1-10

Last Funding Date:

2024-03-11

IPO Status:

Private

Industries:

© 2025 bioDAO.ai